Literature DB >> 15173030

Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion.

William E Hopkins1, Zengyi Chen, Naomi K Fukagawa, Christian Hall, Harm J Knot, Martin M LeWinter.   

Abstract

BACKGROUND: Brain natriuretic peptide (BNP) levels are used in the evaluation of patients with heart disease, yet there is little understanding of the effect of hypoxia on natriuretic peptide secretion. Furthermore, recent data suggest that oxytocin may mediate stretch-induced atrial natriuretic peptide (ANP) secretion. METHODS AND
RESULTS: Ten patients with cyanotic congenital heart defects and 10 control subjects were studied. N-terminal proatrial natriuretic peptide and N-terminal probrain natriuretic peptide levels were 4-fold (P=0.02) and 12-fold (P=0.03) greater in cyanotic patients than in control subjects. Cyanotic patients had reduced body water compared with control subjects, although the difference did not reach statistical significance (P=0.22). In a separate group of patients, cardiac myocytes were isolated from the right atrial appendage during CABG. The amount of oxygen in the buffered saline was varied to simulate hypoxia. Isolated hypoxic atrial myocytes had 43% fewer dense surface secretory granules compared with normoxic myocytes (P<0.0001). Immunohistochemical staining demonstrated decreased ANP and BNP in hypoxic compared with normoxic right atrial tissue. Isolated myocytes also degranulated when incubated with oxytocin (P<0.0001), but there was no difference in oxytocin levels in cyanotic patients compared with control subjects (P=0.49).
CONCLUSIONS: ANP and BNP are markedly elevated in adults with cyanotic congenital heart disease despite reduced body water. Our results show that hypoxia is a direct stimulus for ANP and BNP secretion in human cardiac myocytes. These findings may have implications for the interpretation of BNP levels in the assessment of patients with heart and lung disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15173030     DOI: 10.1161/01.CIR.0000129305.25115.80

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

1.  Serum N-terminal pro-brain natriuretic peptide, a marker of skin thickness in systemic sclerosis?

Authors:  Nicoletta Carlo-Stella; Laura Belloli; Maria Luisa Biondi; Bianca Marasini
Journal:  Clin Rheumatol       Date:  2008-11-28       Impact factor: 2.980

2.  Hypoxia regulates the natriuretic peptide system.

Authors:  Olli Arjamaa; Mikko Nikinmaa
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-09-07

Review 3.  Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart disease.

Authors:  Craig S Broberg; Luke J Burchill
Journal:  Int J Cardiol       Date:  2015-04-10       Impact factor: 4.164

4.  B-type natriuretic peptide identifies silent myocardial ischaemia in stroke survivors.

Authors:  K Y K Wong; S McSwiggan; N S J Kennedy; R S MacWalter; A D Struthers
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

5.  B-type natriuretic peptide can detect silent myocardial ischaemia in asymptomatic type 2 diabetes.

Authors:  B S Rana; J I Davies; M M Band; S D Pringle; A Morris; A D Struthers
Journal:  Heart       Date:  2005-12-09       Impact factor: 5.994

6.  B-type natriuretic peptide in predicting the severity of community-acquired pneumonia.

Authors:  Jing Li; Huan Ye; Li Zhao
Journal:  World J Emerg Med       Date:  2015

7.  Oxytocin-Gly-Lys-Arg: a novel cardiomyogenic peptide.

Authors:  Bogdan A Danalache; Jolanta Gutkowska; Magdalena J Slusarz; Irena Berezowska; Marek Jankowski
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

8.  Exercise testing in adults after repair of aortic coarctation: evaluation of cardiopulmonary exercise capacity and B-type natriuretic protein levels.

Authors:  Olga Trojnarska; Adrian Gwizdala; Magdalena Lanocha; Agnieszka Katarzynska; Slawomir Katarzynski; Zofia Oko-Sarnowska; Andrzej Szyszka; Ewa Chmara
Journal:  Tex Heart Inst J       Date:  2007

9.  Cardiac troponin I, cardiac troponin-specific autoantibodies and natriuretic peptides in children with hypoplastic left heart syndrome.

Authors:  Anneli Eerola; Tuija Poutanen; Tanja Savukoski; Kim Pettersson; Heikki Sairanen; Eero Jokinen; Jaana Pihkala
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-10-06

10.  The Use of N-Terminal-Pro-BNP in Preterm Infants.

Authors:  Afif El-Khuffash; Eleanor Molloy
Journal:  Int J Pediatr       Date:  2009-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.